Elevance Health, Inc.$391.56CI · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B |
| Selling, General & Administrative | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B |
| Interest Expense | $1.40B | $1.50B | $1.40B | $1.30B | $1.30B | $1.40B | $1.60B | $507.00M |
| Other Income / (Expense) | -$1.41B | -$1.44B | -$1.45B | -$1.23B | -$1.21B | -$1.44B | -$1.68B | -$498.00M |
| Income Before Taxes | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B |
| Provision for Income Taxes | $1.49B | $1.49B | $141.00M | $1.61B | $1.37B | $2.38B | $1.45B | $935.00M |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B |
| Basic EPS | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 |
| Diluted EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 |
| Diluted Shares Outstanding | 268.56M | 283.22M | 296.88M | 313.06M | 340.97M | 368.39M | 379.82M | 250.22M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $30.51 | $30.45 | $30.58 | 8 | ↑7 ↓0 |
| Dec 2027 | $33.39 | $32.42 | $33.84 | 10 | ↑4 ↓1 |
| Dec 2028 | $36.87 | $34.56 | $37.92 | 7 | ↑3 ↓1 |
| Dec 2029 | $41.67 | $41.67 | $41.67 | 1 | ↑0 ↓0 |
